Discover all the actions carried out by Jeito and all the partnerships that we set up day after day for the well-being of patients and medical progress.
In the headlines
Jeito Capital co-leads a EUR 104 million financing in Noema Pharma, a clinical-stage biopharma company targeting debilitating central nervous system disorders
Noema Pharma's clinical-stage assets and diversified pipeline hold significant potential in developing effective therapeutic options for patients with debilitating central nervous system (CNS) disorders, addressing high unmet medical needs Jeito Capital's investment...
Find all our press releases
Jeito Capital strengthens its support in Pulmocide with participation in $52 million financing
The Series C extension round will accelerate clinical development, manufacturing scale-up and...
Jeito Capital demonstrates European biopharma leadership with first exit with AstraZeneca acquisition of Neogene Therapeutics
Deal validates Jeito’s unique investment model of selecting high-quality assets developed by...
Jeito Capital co-leads EUR 50 million financing in CatalYm, a clinical-stage biopharma company developing novel immunotherapies for patients with cancer
Jeito Capital co-leads oversubscribed EUR 50 million Series C financing with Brandon Capital...
Jeito Capital becomes significant investor in HI-Bio, a clinical-stage biotech company developing targeted therapies for patients with severe immune-mediated diseases
Jeito Capital participates in $120 million financing alongside ARCH Venture Partners and Monograph...
Jeito Capital appoints new team members to support its growth as a European Private Equity fund leader in life sciences
Bastien Renaud is appointed Chief Financial Officer Evaldo Bifulco, Head of Compliance & Risk,...
NMD Pharma Reports Positive Top-Line Data from a Phase I/IIa Clinical Trial of NMD670 in Patients with Myasthenia Gravis
Aarhus, Denmark, 11 October 2022 - NMD Pharma A/S, a clinical stage biotech company developing...
Face to face
All day long
For more than 25 years, BIO-Europe is one of the most influential life sciences trade shows thanks to the synergies it creates in order to bring out medical innovations.
During this event, Sabine Dandigiuan, Managing Partner of Jeito Capital, will participate in the “Talent: finding it, developing it, keeping it” panel.
All day long
HealthTech Innovation Days 2021
Jeito Capital will be Silver Sponsor at HealthTech Innovation Days 2021.
Attend to Rafaèle Tordjman, MD PhD, Keynote on October, 5 at 6.30 PM CET